Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Etesevimab Emergency use authorization Experimental Antiviral Jan/26/2022 2 11
Bamlanivimab Emergency use authorization Experimental Antiviral Jan/25/2022 4 12
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Dec/24/2021 48 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 87 22
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Apr/10/2021 35 4
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Mar/08/2021 15 2
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Tipranavir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 6 1
Ombitasvir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/20/2021 1 0